Engrafting Costimulator Molecules onto Tumor Cell Surfaces with Chelator Lipids: A Potentially Convenient Approach in Cancer Vaccine Development1

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Immunology

• Publication date

  2000-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.164.5.2433PMID 10679080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD40 activation boosts T cell immunity in vivo by enhancing T cell clonal expansion and delaying peripheral T cell deletion.

  1999cited by this paper
• Orientation and Two-Dimensional Organization of Proteins at Chelator Lipid Interfaces

  1998cited by this paper
• Detection of low-affinity adhesion ligands by linking recombinant cell adhesion molecules in uniform orientation to a fluorescently labelled dextran molecule by means of hexahistidine tagging: the case of multimeric CD40.

  1998cited by this paper
• The role of B7-CD28 co-stimulation in tumor rejection.

  1998cited by this paper
• B7-negative versus B7-positive P815 tumor: differential requirements for priming of an antitumor immune response in lymph nodes.

  1997cited by this paper
• The effect of lipid molecular packing stress on cationic liposome-induced rabbit erythrocyte fusion.

  1997cited by this paper
• B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors.

  1997cited by this paper
• The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretion.

  1997cited by this paper
• Manipulation of T cell response to tumors by targeting on costimulatory pathway.

  1997cited by this paper
• CD80, CD86 and CD40 Provide Accessory Signals in a Multiple‐Step T‐Cell Activation Model

  1996cited by this paper
• Co‐expression of B7‐1 and ICAM‐1 on tumors is required for rejection and the establishment of a memory response

  1995cited by this paper
• Can Co‐stimulated Tumor Immunity be Therapeutically Efficacious?

  1995cited by this paper
• Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules.

  1995cited by this paper
• The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer.

  1995cited by this paper
• Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80).

  1995cited by this paper
• Glycosylphosphatidylinositol-modified murine B7-1 and B7-2 retain costimulator function.

  1995cited by this paper
• Fusion of cationic liposomes with mammalian cells occurs after endocytosis.

  1995cited by this paper
• Synthesis and Characterization of Chelator-Lipids for Reversible Immobilization of Engineered Proteins at Self-Assembled Lipid Interfaces

  1994cited by this paper
• CD40 preferentially costimulates activation of CD4+ T lymphocytes.

  1994cited by this paper
• B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum.

  1994influential reference
• Changes in the lipid dynamics of liposomal membranes induced by poly(ethylene glycol): free volume alterations revealed by inter- and intramolecular excimer-forming phospholipid analogs.

  1994cited by this paper
• Evidence for cell surface association of CD2 and LFA‐1 (CD11a/CD18) on T lymphocytes

  1994cited by this paper
• Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity

  1994cited by this paper
• Tumor eradication by adoptive transfer of cytotoxic T lymphocytes.

  1992cited by this paper
• Metal-Affinity Separations: A New Dimension in Protein Processing

  1991cited by this paper
• Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells.

  1991cited by this paper
• Perspectives on the role of MHC antigens in normal and malignant cell development.

  1989cited by this paper
• Osmotic forces in artificially induced cell fusion.

  1986cited by this paper
• A one‐step procedure for separating mouse T and B lymphocytes

  1974cited by this paper

• Strategies for cell membrane functionalization

  2016cites this paper
• Lipid-Mediated Cell Surface Engineering

  2014cites this paper
• Enhanced delivery of T cells to tumor after chemotherapy using membrane-anchored, apoptosis-targeted peptide.

  2012cites this paper
• A novel liposome-based therapy to reduce complement-mediated injury in revascularized tissues.

  2011cites this paper
• Modulation of antigen presenting cell function to affect innate and adaptive immune responses: implications for organ transplantation.

  2011cites this paper
• Cell Membrane Modification for Rapid Display of Bi-Functional Peptides: A Novel Approach to Reduce Complement Activation

  2010cites this paper
• Targeting of plasmid DNA‐lipoplexes to cells with molecules anchored via a metal chelator lipid

  2009cites this paper
• Convenient targeting of stealth siRNA-lipoplexes to cells with chelator lipid-anchored molecules.

  2009cites this paper
• A Tapestry of Immunotherapeutic Fusion Proteins: From Signal Conversion to Auto-stimulation

  2008cites this paper
• A novel assay for monitoring internalization of nanocarrier coupled antibodies

  2006cites this paper
• Synthesis of an artificial cell surface receptor that enables oligohistidine affinity tags to function as metal-dependent cell-penetrating peptides.

  2006cites this paper
• The novel chelator lipid 3(nitrilotriacetic acid)-ditetradecylamine (NTA(3)-DTDA) promotes stable binding of His-tagged proteins to liposomal membranes: potent anti-tumor responses induced by simultaneously targeting antigen, cytokine and costimulatory signals to T cells.

  2005cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2005cites this paper
• ProtEx™: A Novel Technology to Display Exogenous Proteins on the Cell Surface for Immunomodulation

  2005cites this paper
• Cancer vaccine development

  2004cites this paper
• Rapid Protein Anchoring into the Membranes of Mammalian Cells Using Oleyl Chain and Poly(ethylene glycol) Derivatives

  2004cites this paper
• Targeting Dendritic Cells with Antigen-Containing Liposomes

  2004cites this paper
• Casual cell surface remodeling using biocompatible lipid-poly(ethylene glycol)(n): development of stealth cells and monitoring of cell membrane behavior in serum-supplemented conditions.

  2004cites this paper
• Ciblage in vivo de cellules dendritiques

  2004cites this paper
• New designs for cancer vaccine and artificial veto cells

  2003cites this paper
• Anchoring Cytokines to Tumor Cells for the Preparation of Anticancer Vaccines Without Gene Transfection in Mice

  2003cites this paper
• Novel cancer vaccines prepared by anchoring cytokines to tumor cells avoiding gene transfection

  2002cites this paper
• Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection.

  2002cites this paper
• Does fusion of domains from unrelated proteins affect their folding pathways and the structural changes involved in their function? A case study with the diphtheria toxin T domain.

  2002cites this paper
• A novel approach for modifying tumor cell‐derived plasma membrane vesicles to contain encapsulated IL‐2 and engrafted costimulatory molecules for use in tumor immunotherapy

  2002cites this paper
• Induction of antitumor immunity via intratumoral tetra-costimulator protein transfer.

  2001cites this paper
• Synthesis of the chelator lipid nitrilotriacetic acid ditetradecylamine (NTA-DTDA) and its use with the IAsys biosensor to study receptor-ligand interactions on model membranes.

  2001cites this paper
• Prolonged display or rapid internalization of the IgG-binding protein ZZ anchored to the surface of cells using the diphtheria toxin T domain.

  2001cites this paper
• Ancrer des cytokines aux cellules cancéreuses à l’aide de la toxine diphtérique : mieux que l’immunothérapie par transfert de gène ?

  2001cites this paper
• A novel system for convenient detection of low‐affinity receptor–ligand interactions: Chelator‐lipid liposomes engrafted with recombinant CD4 bind to cells expressing MHC class II

  2001cites this paper
• Designer cancer vaccines made easy: protein transfer of immunostimulatory molecules for use in therapeutic tumor vaccines.

  2001influential citation